Source: Annual Congress 2010 - Exercise training and pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Salhi, C. Haenebalcke, M. Nguyen, S. Perez, J. van Meerbeeck, E. Derom (Bruges, Liege, Brussels, Belgium). Resistance training in radically treated lung cancer patients. Eur Respir J 2010; 36: Suppl. 54, 1941

Member's Comments

No comment yet.

Related content which might interest you: Improvements in lung cancer surgery Source: Annual Congress 2011 - Surgery for lung cancer: pre-operative evaluation and results Year: 2011 Second-line medical treatment for nonsmall cell lung cancer: what happens in reality Source: Annual Congress 2010 - Lung cancer progress after first-line therapy: which treatment makes sense and which does not? Year: 2010 Treatment strategy for patients with locally advanced and metastatic nonsmall-cell lung cancer Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course Year: 2011 Home-based rehabilitation program for lung cancer patients Source: Annual Congress 2011 - Exercise training: new populations, new techniques Year: 2011 Second-line medical treatment for nonsmall cell lung cancer: what the studies say Source: Annual Congress 2010 - Lung cancer progress after first-line therapy: which treatment makes sense and which does not? Year: 2010 Weekly administration of gemcitabine in outpatient clinic for the patients with recurrent non-small cell lung cancer after pulmonary resection Source: Eur Respir J 2006; 28: Suppl. 50, 781s Year: 2006 C-erbB-3 expression in non small cell lung cancer (NSCLC) patients treated by erlotinib Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Effects and feasibility of different types of endurance training in patients with end stage lung disease before lung transplantation Source: Annual Congress 2011 - The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition) Year: 2011 Who should treat lung cancer patients and where should they be treated? Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients Year: 2009 Survival in 138 patients with non small cell lung cancer (NSCLC) treated with platinum together with gemcitabine or vinorelbine by a multidisciplinary team. Comparison with the Big Lung Trial Source: Eur Respir J 2006; 28: Suppl. 50, 781s Year: 2006 Resistance to chemotherapy in lung cancer Source: International Congress 2015 – Resistance to therapy in lung cancer Year: 2015 Swedish Lung Cancer Radiation Study Group: The value of induction chemotherapy for radiotherapy response in patients with non-small cell lung cancer Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Breath biomarkers of lung cancer and other diseases Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease Year: 2010 Pulmonary rehabilitation after radically treated lung cancer patients: a pilot study Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing Year: 2008 6-month follow-up in patients with advanced homogeneous emphysema treated with endobronchial lung sealant therapy Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011 Lung cancer and COPD multidisciplinary teams: Exploring comparisons of patient perceptions Source: Annual Congress 2010 - Optimising the care and management of patients with COPD Year: 2010 Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 The proportion of EGFR+ NSCLC patients never treated with TKI – A single institution Croatian experience Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016